Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 16, 2021 07:00 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update

–Update on FDA Inspection of Buena Facility–Assessing New Growth Opportunities in Injectables–Conference Call to Be Held on August 16, 2021 at 8:30 am Eastern Standard Time –Dial in: (877) 407-0792...
August 11, 2021 16:05 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021

BUENA, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a...
June 30, 2021 11:00 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders

Scheduled to Reconvene on July 21, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 30, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty...
June 18, 2021 11:00 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders

Scheduled to Reconvene on June 30, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 18, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty...
May 25, 2021 07:00 ET | Source: Teligent, Inc.

Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update

–Continued Remediation Progress Being Made–Reiterating Prior Guidance of Informing FDA on Inspection Readiness During 3Q2021–Conference Call to Be Held on May 25, 2021 at 4:30 pm Eastern Standard...
May 21, 2021 16:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020

BUENA, N.J., May 21, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a...
May 03, 2021 18:45 ET | Source: Teligent, Inc.

Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update

– Significantly strengthened balance sheet and cash position – Continued FDA Warning Letter remediation efforts – Anticipate informing FDA on inspection readiness during 3Q2021 – Conference Call to...
April 15, 2021 07:30 ET | Source: Teligent, Inc.

Teligent Announces Hiring of Chief Financial Officer

BUENA, N.J., April 15, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, today announced the hiring...
January 22, 2021 09:00 ET | Source: Teligent, Inc.

Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule

BUENA, N.J., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received notice...
December 31, 2020 15:21 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Third Quarter 2020 Results

BUENA, N.J., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter...